These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 18720234)

  • 21. Influence of different types of commercially available microcrystalline cellulose on degradation of perindopril erbumine and enalapril maleate in binary mixtures.
    Vehovec T; Gartner A; Planinšek O; Obreza A
    Acta Pharm; 2012 Dec; 62(4):515-28. PubMed ID: 23333887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intramolecular cyclization of diketopiperazine formation in solid-state enalapril maleate studied by thermal FT-IR microscopic system.
    Lin SY; Wang SL; Chen TF; Hu TC
    Eur J Pharm Biopharm; 2002 Sep; 54(2):249-54. PubMed ID: 12191699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physicochemical stability of captopril and enalapril extemporaneous formulations for pediatric patients.
    Casas M; Álvarez J; Lucero MJ
    Pharm Dev Technol; 2015 May; 20(3):271-8. PubMed ID: 24279906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simulation and Assignment of the Terahertz Vibrational Spectra of Enalapril Maleate Cocrystal Polymorphs.
    Davis MP; Mohara M; Shimura K; Korter TM
    J Phys Chem A; 2020 Nov; 124(47):9793-9800. PubMed ID: 33185098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and evaluation of a new formulation of enalapril maleate tablet.
    Bibi R; Naqvi BS; Shoaib MH; Rahim N
    Pak J Pharm Sci; 2011 Apr; 24(2):211-5. PubMed ID: 21454172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of the drug-matrix on the stability of enalapril maleate in tablet formulations.
    Al-Omari MM; Abdelah MK; Badwan AA; Jaber AM
    J Pharm Biomed Anal; 2001 Jul; 25(5-6):893-902. PubMed ID: 11377072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preformulation investigation of some clopidogrel addition salts.
    Zupančič V; Smrkolj M; Benkič P; Simonič I; Plevnik M; Ritlop G; Kristl A; Vrečer F
    Acta Chim Slov; 2010 Jun; 57(2):376-85. PubMed ID: 24061734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetics of degradation of enalapril maleate in dosage forms.
    Stanisz B
    Acta Pol Pharm; 2004; 61(6):415-8. PubMed ID: 15794332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In situ salt screening--a useful technique for discovery support and preformulation studies.
    Tong WQ; Whitesell G
    Pharm Dev Technol; 1998 May; 3(2):215-23. PubMed ID: 9653759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reaction kinetics of solid-state cyclization of enalapril maleate investigated by isothermal FT-IR microscopic system.
    Wang SL; Lin SY; Chen TF
    Chem Pharm Bull (Tokyo); 2001 Apr; 49(4):402-6. PubMed ID: 11310665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Solid-state supramolecular synthesis based on the N-H…O heterosynthon: an approach to solve the polymorphism problem in famotidine.
    Russo MG; Brusau EV; Ellena J; Narda GE
    J Pharm Sci; 2014 Nov; 103(11):3754-3763. PubMed ID: 25277273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and characterisation of a range of diclofenac salts.
    O'Connor KM; Corrigan OI
    Int J Pharm; 2001 Sep; 226(1-2):163-79. PubMed ID: 11532579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro and in vivo comparison between crystalline and co-amorphous salts of naproxen-arginine.
    Kasten G; Lobo L; Dengale S; Grohganz H; Rades T; Löbmann K
    Eur J Pharm Biopharm; 2018 Nov; 132():192-199. PubMed ID: 30266670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proposal of a new degradation mechanism of enalapril maleate and improvement of enalapril maleate stability in tablet formulation with different stabilizers.
    Chen J; Zhang LH; Xu RJ; Bu NJ; Zhang L
    Pharmazie; 2014 Apr; 69(4):277-80. PubMed ID: 24791591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new polymorph of ciprofloxacin saccharinate: Structural characterization and pharmaceutical profile.
    Singh P; Chadha R
    J Pharm Biomed Anal; 2017 Nov; 146():7-14. PubMed ID: 28841428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative determination of two polymorphic forms of imatinib mesylate in a drug substance and tablet formulation by X-ray powder diffraction, differential scanning calorimetry and attenuated total reflectance Fourier transform infrared spectroscopy.
    Bellur Atici E; Karlığa B
    J Pharm Biomed Anal; 2015 Oct; 114():330-40. PubMed ID: 26099262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation and characterization of spray-dried co-amorphous drug-amino acid salts.
    Jensen KT; Blaabjerg LI; Lenz E; Bohr A; Grohganz H; Kleinebudde P; Rades T; Löbmann K
    J Pharm Pharmacol; 2016 May; 68(5):615-24. PubMed ID: 26245703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved oral absorption of cilostazol via sulfonate salt formation with mesylate and besylate.
    Seo JH; Park JB; Choi WK; Park S; Sung YJ; Oh E; Bae SK
    Drug Des Devel Ther; 2015; 9():3961-8. PubMed ID: 26251575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of new impurities of enalapril maleate on oxidation in the presence of magnesium monoperoxyphthalate.
    Toporisic R; Mlakar A; Hvala J; Prislan I; Zupancic-Kralj L
    J Pharm Biomed Anal; 2010 Jun; 52(2):294-9. PubMed ID: 20122808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific binding capacity of beta-cyclodextrin with cis and trans enalapril: physicochemical characterization and structural studies by molecular modeling.
    Zoppi A; Quevedo MA; Longhi MR
    Bioorg Med Chem; 2008 Sep; 16(18):8403-12. PubMed ID: 18771929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.